Decision making during a phase III randomized controlled trial.

[1]  S L George,et al.  Stopping a clinical trial early: frequentist and Bayesian approaches applied to a CALGB trial in non-small-cell lung cancer. , 1994, Statistics in medicine.

[2]  R. M. Oliver,et al.  Influence diagrams, belief nets and decision analysis , 1992 .

[3]  D. Sack,et al.  The efficacy in Navajo infants of a conjugate vaccine consisting of Haemophilus influenzae type b polysaccharide and Neisseria meningitidis outer-membrane protein complex. , 1991, The New England journal of medicine.

[4]  M. Santosham,et al.  Safety and immunogenicity of a Haemophilus influenzae type b conjugate vaccine in a high risk American Indian population , 1991, The Pediatric infectious disease journal.

[5]  D A Berry,et al.  Experimental design for drug development: a Bayesian approach. , 1991, Journal of biopharmaceutical statistics.

[6]  L. Joseph,et al.  Bayesian Statistics: An Introduction , 1989 .

[7]  J. Berger.  Statistical Decision Theory and Bayesian Analysis , 1988 .

[8]  S. M. Martin,et al.  Recommendations for the use of Taylor series confidence intervals for estimates of vaccine efficacy. , 1988, Bulletin of the World Health Organization.

[9]  Donald A. Berry,et al.  Interim analysis in clinical trials; the role of the likelihood principle , 1987 .

[10]  Interim analyses in clinical research. , 1987, Cancer investigation.

[11]  A. Hightower,et al.  Immunization of US children with Hemophilus influenzae type b polysaccharide vaccine. A cost-effectiveness model of strategy assessment. , 1985, JAMA.

[12]  J. Coulehan,et al.  Epidemiology of Haemophilus influenzae type B disease among Navajo Indians. , 1984, Public health reports.

[13]  W. Grove.  Statistical Methods for Rates and Proportions, 2nd ed , 1981 .

[14]  J. Fleiss,et al.  Statistical methods for rates and proportions , 1973 .